These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 12087903

  • 1. [Chromosomal aberrations in lymphocytes of patients with systemic lupus erythematosus during cytostatic therapy].
    Latipova NS, Aliavi AL.
    Ter Arkh; 2002; 74(5):35-8. PubMed ID: 12087903
    [Abstract] [Full Text] [Related]

  • 2. Micronucleus frequency in peripheral blood lymphocytes from patients with systemic lupus erythematosus.
    Severin E.
    Rom J Morphol Embryol; 1995; 41(1-2):55-8. PubMed ID: 8680026
    [Abstract] [Full Text] [Related]

  • 3. Intravenous cyclophosphamide for lupus nephritis in Thai children.
    Vachvanichsanong P, Dissaneewate P, Winn T.
    Scand J Rheumatol; 2004; 33(5):339-42. PubMed ID: 15513684
    [Abstract] [Full Text] [Related]

  • 4. [Synchronizing therapy with plasmapheresis and cyclophosphamide in rapidly progressing systemic lupus erythematosis with kidney involvement].
    Demin AA, Sentiakova TN, Smirnov VV, Demina LM, Mamin IV.
    Ter Arkh; 1996; 68(5):27-30. PubMed ID: 9082593
    [Abstract] [Full Text] [Related]

  • 5. [Cyclosporin therapy of patients with systemic lupus erythematosus].
    Gergely P.
    Orv Hetil; 1994 Nov 20; 135(47):2591-5. PubMed ID: 7824258
    [Abstract] [Full Text] [Related]

  • 6. [Severe hyponatraemia secondary to cure of cyclophosphamide (about three cases)].
    Alilou M, Awab A, Zarouf M, Moussaoui RE, Hijri AE, Azzouzi A, Slaoui A.
    Ann Fr Anesth Reanim; 2009 Jan 20; 28(1):103-4. PubMed ID: 19128924
    [No Abstract] [Full Text] [Related]

  • 7. Outpatient monthly oral bolus cyclophosphamide therapy in systemic lupus erythematosus.
    Dawisha SM, Yarboro CH, Vaughan EM, Austin HA, Balow JE, Klippel JH.
    J Rheumatol; 1996 Feb 20; 23(2):273-8. PubMed ID: 8882031
    [Abstract] [Full Text] [Related]

  • 8. An open study of B lymphocyte depletion in systemic lupus erythematosus.
    Leandro MJ, Edwards JC, Cambridge G, Ehrenstein MR, Isenberg DA.
    Arthritis Rheum; 2002 Oct 20; 46(10):2673-7. PubMed ID: 12384926
    [Abstract] [Full Text] [Related]

  • 9. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus.
    Petri M, Jones RJ, Brodsky RA.
    Arthritis Rheum; 2003 Jan 20; 48(1):166-73. PubMed ID: 12528116
    [Abstract] [Full Text] [Related]

  • 10. Immunosuppressive drug therapy of systemic lupus erythematosus.
    Fox DA, McCune WJ.
    Rheum Dis Clin North Am; 1994 Feb 20; 20(1):265-99. PubMed ID: 8153402
    [Abstract] [Full Text] [Related]

  • 11. Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: the PREGO-Study.
    Manger K, Wildt L, Kalden JR, Manger B.
    Autoimmun Rev; 2006 Apr 20; 5(4):269-72. PubMed ID: 16697968
    [Abstract] [Full Text] [Related]

  • 12. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
    Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, Garrido Ed Ede R, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R.
    Arthritis Rheum; 2002 Aug 20; 46(8):2121-31. PubMed ID: 12209517
    [Abstract] [Full Text] [Related]

  • 13. B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus.
    Marks SD, Patey S, Brogan PA, Hasson N, Pilkington C, Woo P, Tullus K.
    Arthritis Rheum; 2005 Oct 20; 52(10):3168-74. PubMed ID: 16200620
    [Abstract] [Full Text] [Related]

  • 14. [Role of gonadotropin releasing hormone analogues for ovarian protection in systemic lupus erythematosus patients treated with cyclophosphamide].
    Liang LQ, Qiu Q, Yang XY, Xu HS, Ye YJ, Zhan ZP, Lian F, Chen DY.
    Zhonghua Yi Xue Za Zhi; 2008 Apr 15; 88(15):1009-11. PubMed ID: 18754430
    [Abstract] [Full Text] [Related]

  • 15. [Invasive disseminated aspergillosis in combined immunosuppressive therapy in systemic lupus erythematosus].
    Teuber G, Schwarting A, Mildenberger P, Schmidt-Brücken G, Moll R, Bornemann A, Wandel E, Wanitschke R, Meyer zum Büschenfelde KH.
    Med Klin (Munich); 1996 Dec 15; 91(12):798-801. PubMed ID: 9082168
    [No Abstract] [Full Text] [Related]

  • 16. Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus.
    Somers EC, Marder W, Christman GM, Ognenovski V, McCune WJ.
    Arthritis Rheum; 2005 Sep 15; 52(9):2761-7. PubMed ID: 16142702
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R, Stojanović R, Novicić-Sasić D, Dimitrijević J, Pavlović S, Stojković D, Palić-Obradović D, Stevanović G, Prodanović S.
    Srp Arh Celok Lek; 2002 Aug 15; 130 Suppl 3():19-25. PubMed ID: 12583309
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Risk factors of ovarian failure in the patients with systemic lupus erythematosus receiving cyclophosphamide therapy].
    Yang XY, Zhu X, Liang LQ, Zhan ZP, Ye YJ.
    Zhonghua Yi Xue Za Zhi; 2005 Apr 13; 85(14):960-2. PubMed ID: 16061002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.